<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03979001</url>
  </required_header>
  <id_info>
    <org_study_id>GABRIELLE 2018</org_study_id>
    <nct_id>NCT03979001</nct_id>
  </id_info>
  <brief_title>Retinal Vascular Network and Obstructive Sleep Apnea</brief_title>
  <acronym>ORNET</acronym>
  <official_title>Pilot Study: Retinal Vascular Network and Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obstructive sleep apnea syndrome (OSA) is thought to lead to systemic vascular lesions that&#xD;
      may be preceded by early microvascular lesions in the eyes and in particular in the retina.&#xD;
      The improvement of ophthalmological imaging techniques by OCTangiography allows a precise&#xD;
      non-invasive study of the retinal microvascular network. This new rapid and non-invasive&#xD;
      retinal imaging tool could reveal micro-vascular lesions related to OSA. To the&#xD;
      investigator's knowledge, this would be the first OCT-angiography description of a cohort of&#xD;
      patients with OSA. If these results are confirmed, it would be interesting to study the&#xD;
      correlation between these micro-vascular lesions and the cardiovascular risk of his patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 6, 2020</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of macular and peri-papillary retinal vascular density of the superficial and deep capillary plexuses</measure>
    <time_frame>Change from baseline at 24 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of macular and peri-papillary retinal infusion density of the superficial and deep capillary plexuses</measure>
    <time_frame>Change from baseline at 24 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of the surface of the macular avascular zone of the superficial and deep capillary plexuses</measure>
    <time_frame>Change from baseline at 24 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Obstructive Sleep Apnea Syndrome</condition>
  <arm_group>
    <arm_group_label>Patients</arm_group_label>
    <description>Patients referred for polysomnography diagnosis of obstructive sleep apnea syndrome</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Person without obstructive sleep apnea syndrome</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>complete ophthalmological examination</intervention_name>
    <description>collection:&#xD;
ophthalmological history and current treatments&#xD;
occular tension measurement&#xD;
measurement of visual acuity (Snellen chart)&#xD;
Axial length measurement&#xD;
Photograph of the posterior segment of the eye&#xD;
3x3 and 6x6 macular and papillary OCT angiography</description>
    <arm_group_label>Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients seen for sleep apnea screening by a pulmonologist and referred for polysomnography&#xD;
        diagnosis of obstructive sleep apnea syndrome&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  person who has given oral consent&#xD;
&#xD;
          -  person who can be followed throughout the study&#xD;
&#xD;
          -  adult&#xD;
&#xD;
        Patient group:&#xD;
&#xD;
        - Patient seen in sleep apnea screening consultation by a pulmonologist and referred for&#xD;
        polysomnography diagnosis of OSA&#xD;
&#xD;
        Control Group:&#xD;
&#xD;
        - Person initially without obstructive sleep apnea syndrome&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  a person who is not affiliated to or not a beneficiary of the national health&#xD;
             insurance system&#xD;
&#xD;
          -  person subject to a measure of legal protection (curatorship, guardianship)&#xD;
&#xD;
          -  person subject to a safeguard of justice&#xD;
&#xD;
          -  pregnant, parturient or breastfeeding woman&#xD;
&#xD;
          -  adult incapable or unable to consent&#xD;
&#xD;
          -  person with a contraindication to Tropicamide or Neosynephrine&#xD;
&#xD;
          -  person with a history of eye disease affecting ocular circulation (examples: acute&#xD;
             anterior ischemic optic neuropathy, retinal central artery occlusion, retinal central&#xD;
             vein occlusion, diabetic retinopathy, glaucoma, uncontrolled hypertonia, AMD, severe&#xD;
             myopia...)&#xD;
&#xD;
        Control Group:&#xD;
&#xD;
          -  person with a history of chronic lung problems (e.g. COPD, chronic respiratory&#xD;
             failure, etc.)&#xD;
&#xD;
          -  person with at least one of the following risk factors for obstructive sleep apnea&#xD;
             syndrome:&#xD;
&#xD;
               -  Obesity with IMCâ‰¥30&#xD;
&#xD;
               -  Alcohol consumption &gt; 3 glasses per day&#xD;
&#xD;
        Exclusion criteria: positive result in one of the 3 self-questionnaires&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pierre-Henry GABRIELLE</last_name>
    <phone>03.80.29.37.56</phone>
    <email>phgabrielle@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chu Dijon Bourogne</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre-Henry Gabrielle</last_name>
      <phone>03.80.29.37.56</phone>
      <email>phgabrielle@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>June 5, 2019</study_first_submitted>
  <study_first_submitted_qc>June 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 7, 2019</study_first_posted>
  <last_update_submitted>January 19, 2021</last_update_submitted>
  <last_update_submitted_qc>January 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

